Chengwei Wu

Statistics

Publications

Citations

760

H-Index

Active since

2003

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Fuzhou University

Zhejiang University

Wenzhou Medical University

Institute of Chemistry, Academia Sinica

Chengwei Wu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, molecular biology, and molecular virology.

ORCID

Publications per year

2003–2023

Publications

Self-Protected DNAzyme Walker with a Circular Bulging DNA Shield for Amplified Imaging of miRNAs in Living Cells and Mice

Yansha Gao, Songbai Zhang, Chengwei Wu et al. · ACS Nano · 2021 · 182 citations

Life Sciences, Biotechnology, Molecular Biology +17

A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors

Thomas J. Tucker, Mark W. Embrey, Candice Alleyne et al. · Journal of Medicinal Chemistry · 2021 · 152 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design

Candice Alleyne, Rupesh P. Amin, Bhavana Bhatt et al. · Journal of Medicinal Chemistry · 2020 · 128 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates

Elisabetta Bianchi, Joseph G. Joyce, Michael D. Miller et al. · Proceedings of the National Academy of Sciences · 2010 · 59 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Bead-String-Shaped DNA Nanowires with Intrinsic Structural Advantages and Their Potential for Biomedical Applications

Yansha Gao, Qian Li, Jingjing Zhang et al. · ACS Applied Materials & Interfaces · 2019 · 52 citations

Pharmacy, Oncology, Pharmaceutics +17

1–5 of 14